Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Investment Company Oak Harvest Opened a Position in Verizon. Is the Stock a Buy?
Via The Motley Fool
Tickers VZ
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates TIPT, SMLR, FITB on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Tickers FITB SMLR TIPT
FLY-E CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urges Fly-E Investors to Contact the Firm Before the November 7th Deadline
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers FLYE
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates RYN, PCH, ATXS on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Tickers ATXS PCH RYN
SAVARA CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Urges Savara, Inc. Investors to Contact the Firm Before November 7th Deadline
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers SVRA
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates TRUE and HI on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Tickers HI TRUE
TRONOX CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Urges Tronox Holdings Investors to Contact the Firm Before November 3rd Deadline
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers TROX
When Smart Money Sees A Credit Crisis Coming
Via Talk Markets
Topics Bonds
Exposures Debt Markets
Liangzhu, where time speaks: Expats explore roots of Chinese civilization
Via Press Release Distribution Service
DOW CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors in Dow, Inc. to Contact the Firm Before the October 28th Deadline
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers DOW
SEMLER CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Semler Scientific Investors to Contact the Firm Before the October 28th Deadline
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers SMLR
Trivolve Tech and Quixy Launch FMS, Bringing Forensic Management to the Cardano Mainnet
Via Zexprwire
Topics Artificial Intelligence
Exposures Artificial Intelligence
LIFEMD CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds LifeMD Investors to Contact the Firm Before the October 27th Deadline
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers LFMD
SNAP CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Snap, Inc. Investors to Contact the Firm Before the October 20th Deadline in the Filed Class Action Lawsuit
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers SNAP
Why The U.S. Dollar Is Set To Fall Further
Via Talk Markets
NUTEX CLASS ACTION DEADLINE: Bragar Eagel & Squire, P.C. Reminds Nutex Health Investors of the October 21st Deadline for the Filed Class Action Lawsuit
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers NUTX
Tesla, Palantir JPMorgan And More — Here's Why Investors Couldn't Stop Talking About These Stocks This Week
Via Benzinga
Tickers JPM OKLO PLTR RGTI TSLA
3 Red-Hot Growth Stocks For Your Watch List
Via Talk Markets
A Turning Point for Humanity: Confronting Factory Farming and Embracing a Plant-Based Future
Via AB Newswire
Topics Climate Change
Exposures Climate
DBI Investor News: If You Have Suffered Losses in Designer Brands Inc. (NYSE: DBI), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers DBI
Week Ahead: Impasses Between U.S. And China And Between Republicans And Democrats
Via Talk Markets
Class Action Announcement for Molina Healthcare, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Molina Healthcare, Inc. - Contact Kessler Topaz Meltzer &amp; Check, LLP
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers MOH
Exposures Financial Legal
Class Action Announcement for Molina Healthcare, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Molina Healthcare, Inc. - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Fraud Lawsuit
Tickers MOH
Exposures Financial Legal
KEYTRUDA® (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Risk of Disease Progression or Death Versus Chemotherapy With or Without Bevacizumab in Certain Patients With Platinum-Resistant Recurrent Ovarian Cancer
From Merck & Co., Inc.
Via Business Wire
Tickers MRK
ENHERTU® (fam-trastuzumab deruxtecan-nxki) reduced the risk of disease recurrence or death by 53% vs. T-DM1 in patients with high-risk HER2-positive early breast cancer following neoadjuvant therapy in DESTINY-Breast05 Phase III trial
From AstraZeneca
Via Business Wire
Tickers AZN
SNAP DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Snap Inc. Investors to Secure Counsel Before Important October 20 Deadline in Securities Class Action – SNAP
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers SNAP
Pfizer, Merck And Astellas Have An 'Enormous New Hope' For Bladder Cancer Patients
Via Investor's Business Daily
Tickers ALPMY MRK PFE
AstraZeneca, In A Buy Zone, Makes A Big Breast Cancer Splash
Via Investor's Business Daily
Tickers AZN
ENHERTU® Reduced the Risk of Disease Recurrence or Death by 53% Versus T-DM1 in Patients with High-Risk HER2 Positive Early Breast Cancer Following Neoadjuvant Therapy in DESTINY-Breast05 Phase 3 Trial
From Daiichi Sankyo
Via Business Wire
ENHERTU® Followed by THP Before Surgery Resulted in a Pathologic Complete Response in 67% of Patients with High-Risk HER2 Positive Early-Stage Breast Cancer in DESTINY-Breast11 Phase 3 Trial
From Daiichi Sankyo
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.